Literature DB >> 7091501

Management of the patient with emphysema, coronary artery disease, and lung cancer.

R M Peters, J A Swain.   

Abstract

Coronary artery disease, emphysema, and lung cancer often occur together and have cigarette smoking as a common etiologic contributor. The management of the patient with lung cancer, coronary artery disease, and emphysema is complex. The patient with significant coronary artery disease should undergo coronary artery bypass before or concurrently with pulmonary resection. Only proven carcinomas should be resected at the time of coronary artery bypass grafting because immunosuppression secondary to cardiopulmonary bypass can result in the life-threatening spread of fungal or other infections if biopsy is performed at the time of cardiopulmonary bypass. The risk of pulmonary resection is increased in the patient with emphysema because of decreased efficiency of the lungs and chest wall. Likewise, emphysema results in greater risk in the patient with coronary artery disease because of increased demands on the heart.

Entities:  

Mesh:

Year:  1982        PMID: 7091501     DOI: 10.1016/0002-9610(82)90040-x

Source DB:  PubMed          Journal:  Am J Surg        ISSN: 0002-9610            Impact factor:   2.565


  4 in total

1.  Transverse sternotomy for concomitant cardiac and pulmonary surgery.

Authors:  E E Eren; D A Ott
Journal:  Tex Heart Inst J       Date:  1984-06

2.  Concomitant cardiac and pulmonary operations for lung cancer.

Authors:  S La Francesca; O H Frazier; B Radovancĕvić; L F De Caro; G J Reul; D A Cooley
Journal:  Tex Heart Inst J       Date:  1995

3.  Preoperative laser therapy in a patient with resectable bronchogenic carcinoma and severe coronary artery disease.

Authors:  J Powney; A D Scott; P J George; R O Feneck; J Wright; N C Barnes
Journal:  Thorax       Date:  1992-12       Impact factor: 9.139

4.  Management and postoperative outcome in primary lung cancer and heart disease co-morbidity: a systematic review and meta-analysis.

Authors:  George D Bablekos; Antonis Analitis; Stylianos A Michaelides; Konstantinos A Charalabopoulos; Anastasia Tzonou
Journal:  Ann Transl Med       Date:  2016-06
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.